Clinical Trial Update: Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine [Phase 4]

View source ↗

Summary

Phase 4 study assessing whether methylnaltrexone alters the pharmacokinetics and pharmacodynamics of ticagrelor in coronary artery disease patients treated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BRILINTA (ticagrelor)
• RELISTOR (methylnaltrexone)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-04-27